IDEVAX
Vanessa Vankerckhoven is a CEO, Co-Founder, and Director at Idevax, as well as a Co-Founder, Director, and Managing Director at Novosanis. Vanessa is also a Council Member at VARIO Flemish Advisory Council for Innovation and Enterprise and a Guest Professor at UAntwerpen, where Vanessa is involved in research and education at the Faculty of Medicine and Health Sciences. Prior to these roles, Vanessa served as a Research and Innovation Manager at the University of Antwerp and conducted research on enterococci at the University Hospital Antwerp. Vanessa holds a PhD in Medical Sciences, a Master of Business Administration specializing in Life Sciences & Health, and a Master's degree in Biomedical Sciences.
This person is not in any teams
This person is not in any offices
IDEVAX
VAX-ID®, the heart of the Idevax company, is an award-winning patented drug delivery device platform suited for intradermal injection. The device can be preconfigured with a 32G needle as well as with a 27G needle to allow for different applications, with a penetration depth of 0.85 and 1.2mm respectively. The device is suited for accurate and reliable drug delivery of therapeutic and prophylactic medicinal substances in the dermal layer of the skin of both humans and animals.